Theragen Etex (Korea) Today
| 066700 Stock | KRW 3,135 125.00 4.15% |
Performance0 of 100
| Odds Of DistressLess than 32
|
Theragen Etex is trading at 3135.00 as of the 11th of December 2024, a 4.15 percent increase since the beginning of the trading day. The stock's open price was 3010.0. Theragen Etex has about a 32 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 11th of November 2024 and ending today, the 11th of December 2024. Click here to learn more.
,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. ,Ltd. was founded in 1987 and is headquartered in Seoul, South Korea. THERAGEN ETEX is traded on Korean Securities Dealers Automated Quotations in South Korea.. The company has 30.48 M outstanding shares. More on Theragen Etex CoLtd
Moving together with Theragen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Theragen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Theragen Etex's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Theragen Etex or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Tae Hwang |
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Theragen Etex CoLtd (066700) is traded on KOSDAQ in Korea and employs 164 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 143.39 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theragen Etex's market, we take the total number of its shares issued and multiply it by Theragen Etex's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Theragen Etex CoLtd operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 30.48 M outstanding shares.
Theragen Etex CoLtd has accumulated about 12.17 B in cash with 4.01 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 380.87.
Check Theragen Etex Probability Of Bankruptcy
Ownership AllocationTheragen Etex CoLtd shows a total of 30.48 Million outstanding shares. Theragen Etex CoLtd has 16.91 % of its outstanding shares held by insiders and 1.39 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Theragen Ownership Details
Theragen Etex CoLtd Risk Profiles
Although Theragen Etex's alpha and beta are two of the key measurements used to evaluate Theragen Etex's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.52 | |||
| Standard Deviation | 2.12 | |||
| Variance | 4.48 | |||
| Risk Adjusted Performance | (0.10) |
Theragen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Theragen Etex without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Theragen Etex Corporate Directors
Other Information on Investing in Theragen Stock
Theragen Etex financial ratios help investors to determine whether Theragen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theragen with respect to the benefits of owning Theragen Etex security.